Pulse Biosciences announces $60 million rights offering By Investing.com

Published on 28 Mar 2024 on Investing.com

Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a...

Read the rest of the article

Start tracking your investments with Statfolio

Quite a few insiders have dramatically grown their holdings in Pulse Biosciences, Inc. (NASDAQ:PL...

Simply Wall St. via Yahoo Finance 11 May 2024

Shares of Nuvve Holding Corp. NVVE fell sharply during Monday’s session after the company report...

Benzinga 1 Apr 2024

Pulse Biosciences, Inc. (NASDAQ: PLSE ) has reported significant regulatory and development...

Investing.com 1 Apr 2024

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript March 28, 2024 Pulse Biosc...

Insider Monkey via Yahoo Finance 1 Apr 2024

Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a...

Investing.com 28 Mar 2024

Key Insights Pulse Biosciences' significant insider ownership suggests inherent interests in comp...

Simply Wall St. via Yahoo Finance 7 Jan 2024

Pulse Biosciences, Inc. (NASDAQ:PLSE) shareholders (or potential shareholders) will be happy to s...

Simply Wall St. via Yahoo Finance 3 Dec 2023

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2023 Earnings Call Transcript November 13, 2023 Operator...

Insider Monkey via Yahoo Finance 14 Nov 2023

Pulse Biosciences Inc (NASDAQ:PLSE) announced a reduced GAAP net loss of $10.6 million in Q3 2023...

GuruFocus.com via Yahoo Finance 13 Nov 2023

Over the last year, a good number of insiders have significantly increased their holdings in Puls...

Simply Wall St. via Yahoo Finance 21 Sep 2023